MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$2,967,063
EPS
-$0.74
Unit: Dollar
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
212,563
383,724
1,398,732*
504,387
Selling, general and administrative (including related party amounts of 428,966 and 619,549 for the three and six months ended june 30, 2026, respectively, and 0 for the three and six months ended june 30, 2025)
2,801,004
1,542,658
1,074,763*
1,256,284
Total operating expenses
3,013,567
1,926,382
2,473,495
1,760,671
Loss from operations
-3,013,567
-1,926,382
-2,473,495*
-1,760,671
Interest income
46,504
78,676
4,561*
68,682
Net loss
-2,967,063
-1,847,706
-2,468,934
-1,691,989
Basic EPS
-0.74
-0.48
-3.403
-1.65
Diluted EPS
-0.74
-0.48
-3.403
-1.65
Basic Average Shares
4,022,143
3,858,921
725,613
1,026,457
Diluted Average Shares
4,022,143
3,858,921
725,613
1,026,457
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net loss-$2,967,063 (-74.42%↓ Y/Y)Interest income$46,504 (-35.08%↓ Y/Y)Loss from operations-$3,013,567 (-70.00%↓ Y/Y)Total operatingexpenses$3,013,567 (70.00%↑ Y/Y)Selling, general andadministrative (including...$2,801,004 Research and development$212,563 (-65.60%↓ Y/Y)

Dermata Therapeutics, Inc. (DRMAW)

Dermata Therapeutics, Inc. (DRMAW)